First Patient in COMBACTE-CARE’s REJUVENATE Study
It is with great pleasure that we announce the recruitment of the first patients in COMBACTE-CARE’s REJUVENATE study. José Miguel Cisneros Herreros from the University Hospital Virgen del Rocio, Jesús Rodríguez-Baño and Luis Tallón's team from Hospital Universitario Virgen Macarena, enrolled the first patients on the 19th and 26th of May respectively. COMBACTE-CARE, a project with 18 academic and 3 pharmaceutical partners, led by AstraZeneca as the coordinator and The University of Utrecht as the managing entity, aims to better understand the clinical management and outcomes of hospitalized patients with (CRE) infections. Read more..